Anavex Life Sciences (AVXL) Depreciation & Amortization (CF) (2010 - 2016)
Anavex Life Sciences (AVXL) reported Depreciation & Amortization (CF) of $506.0 for Q3 2016, up 103.21% on a YoY basis from $249.0 in Q4 2015, and up 103.21% sequentially from $249.0 in Q2 2016.
Anavex Life Sciences (AVXL) Depreciation & Amortization (CF) (2010 - 2016) Analysis & Trends
Anavex Life Sciences (AVXL) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $506.0 in Q3 2016.
- For the quarter ending Q3 2016, Depreciation & Amortization (CF) rose 103.21% year-over-year to $506.0; the trailing twelve-month figure through Jun 2017 stood at $506.0 (down 49.15% YoY), and the FY2016 full-year result was $1252.0, up 25.83% from the prior year.
- Depreciation & Amortization (CF) grew to $506.0 in Q3 2016, from $249.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $506.0 in Q3 2016 to a low of $111.0 in Q1 2013.
- A 5-year average of $293.24 and a median of $249.0 in 2014 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) plunged 76.13% in 2013 and jumped 103.21% in 2016, its largest moves.
- Tracing AVXL's Depreciation & Amortization (CF) over 5 years: stood at $465.0 in 2012, then plunged by 58.71% to $192.0 in 2013, then climbed by 29.69% to $249.0 in 2014, then changed by 0.0% to $249.0 in 2015, then jumped by 103.21% to $506.0 in 2016.
- Business Quant data shows AVXL's Depreciation & Amortization (CF) at $506.0 in Q3 2016, $249.0 in Q2 2016, and $248.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 506.00 |
| Sep 30, 2016 | 506.00 |
| Jun 30, 2016 | 249.00 |
| Jun 30, 2016 | 249.00 |
| Mar 31, 2016 | 248.00 |
| Mar 31, 2016 | 248.00 |
| Dec 31, 2015 | 249.00 |
| Dec 31, 2015 | 249.00 |
| Sep 30, 2015 | 249.00 |
| Sep 30, 2015 | 249.00 |
| Jun 30, 2015 | 248.00 |
| Jun 30, 2015 | 248.00 |
| Mar 31, 2015 | 249.00 |
| Mar 31, 2015 | 249.00 |
| Dec 31, 2014 | 249.00 |
| Dec 31, 2014 | 249.00 |
| Sep 30, 2014 | 192.00 |
| Sep 30, 2014 | 192.00 |
| Jun 30, 2014 | 192.00 |
| Jun 30, 2014 | 192.00 |